Search by Drug Name or NDC

    NDC 51655-0317-52 Clindamycin Hydrochloride 300 mg/1 Details

    Clindamycin Hydrochloride 300 mg/1

    Clindamycin Hydrochloride is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Northwind Pharmaceuticals, LLC. The primary component is CLINDAMYCIN HYDROCHLORIDE.

    Product Information

    NDC 51655-0317
    Product ID 51655-317_f2f080c9-d9fa-6e3a-e053-2a95a90aba97
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Clindamycin Hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Clindamycin Hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 300
    Active Ingredient Units mg/1
    Substance Name CLINDAMYCIN HYDROCHLORIDE
    Labeler Name Northwind Pharmaceuticals, LLC
    Pharmaceutical Class Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA065442
    Listing Certified Through 2024-12-31

    Package

    NDC 51655-0317-52 (51655031752)

    NDC Package Code 51655-317-52
    Billing NDC 51655031752
    Package 30 CAPSULE in 1 BOTTLE, PLASTIC (51655-317-52)
    Marketing Start Date 2023-03-10
    NDC Exclude Flag N
    Pricing Information N/A